Renvela and Lexiva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Renvela (sevelamer carbonate) and Lexiva (fosamprenavir calcium). Common drug interactions include anhedonia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Renvela and Lexiva. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Lexiva?

Lexiva has active ingredients of fosamprenavir calcium. It is often used in hiv infection. eHealthMe is studying from 1,408 Lexiva users. Check the latest studies of Lexiva.



On Jul, 15, 2026

14 people who take Renvela and Lexiva together, and have interactions are studied.

Renvela and Lexiva drug interactions.

What are the common drug interactions of Renvela and Lexiva, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal disorder (kidney disease)
  7. Blood creatinine increased
  8. Fatigue (feeling of tiredness)
  9. Quality of life decreased
  10. Bone density decreased

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Quality of life decreased
  5. Anaemia (lack of blood)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Renal cyst (kidney cyst)
  8. Renal transplant
  9. Emotional distress
  10. Pain

What are the common drug interactions of Renvela and Lexiva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Decreased activity
  5. Emotional distress
  6. Pain
  7. Quality of life decreased
  8. Renal disorder (kidney disease)
  9. Renal failure (kidney dysfunction)

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Decreased activity
  5. Emotional distress
  6. Pain
  7. Quality of life decreased
  8. Renal disorder (kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Blood creatinine increased

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Fatigue (feeling of tiredness)
  6. Quality of life decreased
  7. Renal failure (kidney dysfunction)
  8. Chronic kidney disease
  9. Impaired work ability
  10. Mobility decreased (ability to move is reduced)

40-49:

  1. Blood creatinine increased
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Skeletal injury (bone and supporting muscle injury)
  4. Anaemia of chronic disease
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Renal transplant
  7. Anxiety
  8. Emotional distress
  9. Fatigue (feeling of tiredness)
  10. Pain

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 4 people, 28.57%
  2. High Blood Pressure: 4 people, 28.57%
  3. Rickets (softening of bones): 3 people, 21.43%
  4. Arrhythmias (irregular heartbeat): 3 people, 21.43%
  5. Inflammation: 3 people, 21.43%
  6. Infection: 3 people, 21.43%
  7. Blood Calcium Decreased: 3 people, 21.43%
  8. Blood Potassium Decreased: 3 people, 21.43%
  9. Chest Pain: 3 people, 21.43%
  10. Cough: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and Lexiva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Renvela and Lexiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lexiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renvela and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexiva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer carbonate and fosamprenavir calcium (the active ingredients of Renvela and Lexiva, respectively), and Renvela and Lexiva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: